RXDX-101

Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress
Yahoo/BusinessWire
Sun, 09/28/14 - 09:43 am
Ignyta
RXDX-101
non-small cell lung cancer